BEDFORD, Mass. (AP) — BEDFORD, Mass. (AP) — Ocular Therapeutix Inc. (OCUL) on Monday reported a loss of $94.8 million in its third quarter. On a per-share basis, the Bedford, Massachusetts-based company said it had a loss of 42 cents. The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks...